Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group. (Q39873557)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 February 2009

Language	Label	Description	Also known as
English	Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group.	scientific article published on 12 February 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Münster study group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

C Prucker

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

A Attarbaschi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

M N Dworzak

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

C Urban

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

F-M Fink

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

B Meister

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

K Schmitt

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

O A Haas

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

H Gadner

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

G Mann

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Austrian Berlin-Frankfurt-Münster (BFM) Study Group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

12 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1264-1269

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19212332%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Remission death in acute lymphoblastic leukaemia: a changing pattern

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the "BFM Family" Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Invasive fungal infections are responsible for one-fifth of the infectious deaths in children with ALL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemi

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian children

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Sex-associated hormones and immunity to protozoan parasites.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

21 January 2018

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992-2001

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2009.12

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39873557&oldid=2203231467"